sacituzumab
gilead sciences
['mbc', 'sacituzumab', 'tropics2']
tropics2 . sacituzumab shows os benifit 3.2 months . statistically significant. hr 0.79 . in hr + her2 negative mbc . #esmo2022 
Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twists